
The Surprising Stock Insiders Can’t Stop Buying: What’s the Hype?
Sionna Therapeutics, Inc. is an emerging biopharmaceutical company listed on Nasdaq under the ticker SION, focused on developing treatments for cystic fibrosis. Insiders, including Director Peter A. Thompson, have demonstrated significant confidence by purchasing over $62 million in shares during the company’s